Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Endokrynologia Polska|July 6, 2006
[Hyperprolactinaemia--pitfalls in PRL assessment]Wojciech Zgliczyński, Piotr ZdunowskiEndokrynologia Polska|December 7, 2007
[Pegvisomant--growth hormone receptor antagonist in the treatment of acromegaly]Wojciech Zgliczyński, Piotr ZdunowskiEndokrynologia Polska|February 19, 2009
Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms?Maria Stelmachowska-Banaś, Piotr Zdunowski, Wojciech ZgliczyńskiNeuro Endocrinology Letters|November 7, 2007
In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and genderWojciech Zgliczynski, Magdalena Kochman, Waldemar Misiorowski, et al.Neuro Endocrinology Letters|December 29, 2005
ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndromeAnna A Kasperlik-Załuska, Wojciech Zgliczyński, Wojciech Jeske, et al.Neurologia I Neurochirurgia Polska|November 22, 2011
The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegalyMaria Stelmachowska-Banaś, Grzegorz Zieliński, Piotr Zdunowski, et al.Contemporary Oncology (Poznan, Poland)|March 6, 2014
Assessment of real-world usage of lanreotide AUTOGEL 120 in Polish acromegalic patients - results from the prospective 12-month phase of Lanro-StudyEwa Orlewska, Beata Kos-Kudła, Jerzy Sowiński, et al.Pageof 1